Evidence map›Paper›PMID 41316163›Full record

ArticleLipids in health and disease2025

Associations of the Zhejiang University (ZJU) index with cardiovascular diseases and mortality among US adults: a national cohort study.

Zhenzhen Mo, Bilian Chen, Minyi Wu

Abstract read
In one paragraph

Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhenzhen MoThe Third Hospital of Changsha (Changsha Hospital Affiliated to Hunan University), Changsha City, 410015, Hunan Province, People's Republic of China.
Bilian ChenDepartment of Geriatrics, National Geriatrics Clinic Center, Xiangya Hospital, Central South University, Changsha, 87 Xiangya Road, 410008, People's Republic of China.
Minyi WuThe Third Hospital of Changsha (Changsha Hospital Affiliated to Hunan University), Changsha City, 410015, Hunan Province, People's Republic of China. wuminy0213@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Zhejiang University (ZJU) Index, a composite metabolic indicator incorporating body mass index (BMI), fasting plasma glucose (FPG), triglycerides (TG), and alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio, is associated with abnormalities like dyslipidemia and glucose intolerance. Yet its clinical significance in cardiovascular disease (CVD) is underinvestigated, and this study aims to clarify its associations with prevalent CVD, all-cause mortality, and CVD mortality.

methodsThe study included 18,609 adults from the National Health and Nutrition Examination Survey (NHANES) spanning 1999-2018. Associations of the ZJU Index with prevalent CVD were evaluated using multivariable Logistic regression. Associations with all-cause mortality and CVD mortality were assessed using multivariable Cox proportional hazards regression. Restricted cubic spline (RCS) regression and ROC curve analyses were further used to explore non-linear relationships and predictive performance, respectively. Sensitivity analyses, which included excluding participants who died within 2 years and those with baseline CVD, confirmed the robustness of the findings.

resultsAmong 18,609 participants, 2,121 had CVD (9.0% weighted prevalence). Logistic regression showed a positive association of the ZJU Index with prevalent CVD risk: after full adjustment, a 1-unit increase was linked to a 2% higher risk (OR = 1.02, 95% CI 1.01-1.03, P < 0.001), and participants in the highest quartile (Q4) had a 50% higher risk than those in the lowest quartile (Q1) (OR = 1.50, 95% CI 1.22-1.84, P < 0.001). Significant non-linearity between the ZJU Index and prevalent CVD was confirmed (P < 0.001). Over a median 71-month follow-up (36-121 months), 2,752 all-cause deaths (11.1% weighted rate) and 934 CVD deaths (3.4% weighted rate) occurred. After full adjustment, the association persisted for CVD mortality (Q4 vs. Q1: HR = 1.30, 95% CI 1.03-1.63, P = 0.027). Restricted cubic spline (RCS) analysis revealed that the ZJU Index had a U-shaped relationship with all-cause mortality and a J-shaped relationship with CVD mortality (both P < 0.001). Sensitivity analyses supported the robustness of these findings.

conclusionsIn conclusion, whether analyzed as a continuous or categorical variable, a higher ZJU Index is significantly associated with higher risks of CVD and CVD mortality, while it shows a U-shaped relationship with all-cause mortality. This indicates that the ZJU Index holds potential as a CVD risk stratification tool to identify high-risk individuals and guide targeted interventions. However, its utility as a CVD screening tool requires further validation to confirm optimal cut-offs and compatibility with existing protocols.

Indexed as

Cardiovascular DiseasesAdultAgedAlanine TransaminaseAspartate AminotransferasesBlood GlucoseBody Mass IndexChinaCohort StudiesFemaleHumansMaleMiddle AgedNutrition SurveysPrevalenceRisk FactorsAlanine TransaminaseAspartate AminotransferasesBlood GlucoseTriglyceridesAll-cause mortalityCardiovascular diseaseCardiovascular mortalityNonlinear relationshipZJU index

Identifiers

PMID41316163
PMCPMC12661696

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.